HK Stock MarketDetailed Quotes

03759 PHARMARON

Watchlist
  • 8.580
  • +0.010+0.12%
Not Open Jul 16 16:08 CST
15.34BMarket Cap9.38P/E (TTM)

PHARMARON Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

PHARMARON Earnings Date

Currency: CNY

Period

Q1 FY2024 Earnings

Apr 26, 2024

Revenue(YoY)

2.67B

-1.95%
EPS(YoY)

0.13

-55.14%
Analyst Rating

Strong Buy

Jul 16, 2024

PHARMARON Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.216B--
Aug 28, 20242024/Q2-- / 2.983B--
Mar 28, 20242023/Q42.978B / 3.191B--
Oct 27, 20232023/Q32.920B / 3.350B--
Aug 25, 20232023/Q22.916B / 3.080B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 3.216B--
Aug 28, 20242024/Q2-- / 2.983B--
Mar 28, 20242023/Q42.978B / 3.191B--
Oct 27, 20232023/Q32.920B / 3.350B--
Aug 25, 20232023/Q22.916B / 3.080B--

Unlock Free Earnings Estimates

PHARMARON Earnings Reports

  • (I) POLL RESULTS OF THE ANNUAL GENERAL MEETING OF 2023,THE FIRST A SHARE CLASS MEETING OF 2024 ANDTHE FIRST H SHARE CLASS MEETING OF 2024 HELD ON JUNE 6, 2024;(II) THE 2023 PROFIT DISTRIBUTION PLAN;AND(III) AMENDMENTS TO THE ARTICLES OF ASSOCIATION

    Jun 6 10:07 ET

  • NOTICE OF THE ANNUAL GENERAL MEETING OF 2023

    May 14 04:35 ET

  • 2023 ANNUAL REPORT

    Apr 29 09:00 ET

  • PHARMARON: 2024 FIRST QUARTERLY REPORT

    Apr 25 08:57 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 16, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    HK
    Overall
    Symbol
    Latest Price
    %Chg